Literature DB >> 27527838

Myeloma today: Disease definitions and treatment advances.

Vincent Rajkumar.   

Abstract

Entities:  

Year:  2016        PMID： 27527838     DOI： 10.1002/ajh.24392

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

Review 1.  [Monoclonal gammopathy of undetermined significance and multiple myeloma].

Authors:  M Schmalzing; H-P Tony; S Knop
Journal:  Z Rheumatol       Date:  2017-10       Impact factor: 1.372

Review 2.  Cytokines in Endocrine Dysfunction of Plasma Cell Disorders.

Authors:  Eva Feigerlová; Shyue-Fang Battaglia-Hsu
Journal:  Mediators Inflamm       Date:  2017-06-27       Impact factor: 4.711

3.  Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG study.

Authors:  Joseph Mikhael; Judith Manola; Amylou C Dueck; Suzanne Hayman; Kurt Oettel; Abraham S Kanate; Sagar Lonial; S Vincent Rajkumar
Journal:  Blood Cancer J       Date:  2018-08-29       Impact factor: 11.037

4.  Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib-sensitivity in multiple myeloma via ERK/STAT3 axis.

Authors:  Zhaoyuan Zhang; Weili Wang; Dan Ma; Jie Xiong; Xingyi Kuang; Siyu Zhang; Qin Fang; Jishi Wang
Journal:  Aging (Albany NY)       Date:  2020-04-16       Impact factor: 5.682
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.